Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
To see if you qualify, visit the Wegovy Savings Card eligibility page
A consultation can help determine if this therapy is right for you
Consistent, low-level therapy typically outperforms intermittent dosing or extended pauses in preserving weight loss outcomes
Semaglutide also suppresses glucagon release, slows gastric emptying, and acts on appetite centers in the brain to promote satiety
[8] [9] Comorbidities and concomitant medicines : Patients with type 2 diabetes particularly those taking insulin or sulfonylureas should discuss timing with their clinical team, as reduced appetite following injection may increase the risk of hypoglycaemia and may require dose adjustment of those medicines
Research Use Disclaimer For laboratory and scientific research use only
